Traders bought shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading hours on Tuesday. $68.88 million flowed into the stock on the tick-up and $54.74 million flowed out of the stock on the tick-down, for a money net flow of $14.14 million into the stock. Of all equities tracked, UnitedHealth Group had the 20th highest net in-flow for the day. UnitedHealth Group traded down ($0.08) for the day and closed at $142.01

Several research analysts have recently commented on the company. Credit Suisse Group AG reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, May 18th. Zacks Investment Research cut UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Monday, July 18th. Morgan Stanley reissued a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, May 18th. Leerink Swann reissued a “buy” rating on shares of UnitedHealth Group in a report on Monday, June 27th. Finally, FBR & Co reissued an “outperform” rating and set a $155.00 price target (up from $145.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. One analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $153.44.

The firm has a market cap of $135.25 billion and a P/E ratio of 22.22. The stock’s 50-day moving average price is $142.04 and its 200 day moving average price is $132.55.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.89 by $0.07. The business earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. On average, analysts predict that UnitedHealth Group Inc. will post $7.91 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Investors of record on Friday, September 9th will be given a $0.625 dividend. The ex-dividend date of this dividend is Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.76%.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,500 shares of the firm’s stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $139.80, for a total transaction of $768,900.00. Following the sale, the director now owns 59,019 shares in the company, valued at $8,250,856.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Thursday, June 16th. The shares were sold at an average price of $138.58, for a total value of $692,900.00. Following the sale, the director now owns 72,229 shares in the company, valued at approximately $10,009,494.82. The disclosure for this sale can be found here.

A number of large investors have recently added to or reduced their stakes in the stock. Wafra Investment Advisory Group Inc. NY increased its stake in UnitedHealth Group by 18.1% in the fourth quarter. Wafra Investment Advisory Group Inc. NY now owns 222,661 shares of the healthcare conglomerate’s stock worth $26,194,000 after buying an additional 34,057 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in UnitedHealth Group by 3.2% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 2,825,116 shares of the healthcare conglomerate’s stock worth $332,347,000 after buying an additional 88,802 shares during the last quarter. King Luther Capital Management Corp increased its stake in UnitedHealth Group by 23.4% in the fourth quarter. King Luther Capital Management Corp now owns 15,723 shares of the healthcare conglomerate’s stock worth $1,850,000 after buying an additional 2,978 shares during the last quarter. American International Group Inc. increased its stake in UnitedHealth Group by 0.8% in the fourth quarter. American International Group Inc. now owns 454,179 shares of the healthcare conglomerate’s stock worth $53,429,000 after buying an additional 3,479 shares during the last quarter. Finally, Montag A & Associates Inc. increased its stake in UnitedHealth Group by 52.6% in the fourth quarter. Montag A & Associates Inc. now owns 21,570 shares of the healthcare conglomerate’s stock worth $2,537,000 after buying an additional 7,435 shares during the last quarter.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.